Erythrocytosis incidence and thromboembolic risk in heart failure with reduced ejection fraction treated with SGLT2 inhibitors: a nationwide register-based cohort study by Abdullahi Ahmed Mohamed, Camilla Fuchs Andersen, Daniel Mølager Christensen, Lise Da Riis-Vestergaard, Milan Mohammad, Mariam Elmegaard, Casper Binding, Christian Torp-Pedersen, Tor Biering-Sørensen, Morten Lock Hansen, Lars Køber, Andreas Glenthøj, Jesper Jensen, Charlotte Andersson, Morten Schou, Gunnar Gislason

Get full text